Trade Ideas April 24, 2026 10:52 AM

Intel's AI Comeback - Trading the Beat into a High-Conviction Long

Q1 blowout and CPU-led AI demand justify a targeted long; manage execution around elevated momentum and stretched technicals.

By Ajmal Hussain INTC
Intel's AI Comeback - Trading the Beat into a High-Conviction Long
INTC

Intel's Q1 2026 results and updated guidance reframed the company as a core AI infrastructure play. Revenue of $13.58B and adjusted EPS of $0.29 surprised the market, data center sales grew 22%, and management says AI-related businesses now represent roughly 60% of revenue. The stock has ripped higher, so this is a structured long: enter at $82.75, stop at $70.00, primary target $120.00 over a 180 trading-day horizon, with intermediate profit-taking along the way.

Key Points

  • Q1 2026 adjusted EPS $0.29 and revenue $13.58B; data-center revenue grew 22% and AI-related businesses represent ~60% of revenue.
  • Current snapshot market cap ~$415.5B; enterprise value ~$367.6B; EV/EBITDA ~31.5 and EV/Sales ~7.0 reflect a re-rating.
  • Entry $82.75, Stop $70.00, Target $120.00 with a long-term horizon (180 trading days); partial profit-taking at $95 and $105 recommended.
  • Technicals show strong momentum (RSI ~82, bullish MACD) and heavy volume, but short interest days-to-cover are low, increasing reversion risk.

Hook & thesis
Intel just handed the market a clear narrative shift: from a long-restructuring turnaround story to an actionable AI infrastructure incumbent. The company beat Q1 expectations with adjusted EPS of $0.29 on $13.58 billion in revenue, saw its data-center business grow 22%, and management says AI-related businesses now account for about 60% of revenue.

That combination - meaningful top-line growth driven by CPUs and packaging, plus upgraded guidance - pushed the stock sharply higher on 04/24/2026. This is a trade idea that leans into momentum but forces discipline: enter at $82.75, place a stop at $70.00, and target $120.00 with a primary horizon of long term (180 trading days). The logic is straightforward: the market is repricing Intel as a prime beneficiary of agentic AI deployments where CPUs and advanced packaging remain critical. Execution risk and valuation optimism are the main offsets, so position sizing and a clear stop are essential.

Why the market should care - business plus fundamental driver
Intel remains a diversified semiconductor platform company with four reporting segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS) and All Other. The immediate driver is DCAI. Customers building large-scale, agentic AI systems need a mix of compute - not just accelerators - and recent product and packaging wins have put Intel back in the conversation.

Concrete numbers matter: Intel reported $13.58B in revenue for Q1 2026 and adjusted EPS of $0.29 on 04/24/2026. The data-center business grew 22%, and management characterized AI-related businesses as roughly 60% of revenue with 40% year-over-year growth in that cohort. Those figures indicate demand that is meaningfully above legacy trends and justify a premium re-rating versus the depressed multiples the company traded at a year ago.

Supporting evidence from the market snapshot and technicals
The market is already pricing the narrative. Snapshot data shows today's trading range $80.64 - $85.22 with the current price around $82.75, and a new 52-week high of $85.22. Average volume over recent periods is elevated (two-week average ~107.6M), and the stock printed a heavy volume day (~146.7M) on the move higher, signaling institutional participation. Technical indicators are bullish but stretched: 10-day SMA sits at $67.77 while the 9-day EMA is $68.30, and the RSI is at ~82.27 - overbought by conventional readings. MACD shows bullish momentum with a positive histogram.

On fundamentals, enterprise-value metrics are still instructive: enterprise value stands around $367.6B with EV/EBITDA roughly 31.47 and EV/Sales about 6.96 based on the most recent snapshot. Trailing free cash flow is negative (free cash flow -$4.949B), reflecting ongoing capital intensity as Intel scales fabs and transitions its product stack. Debt is moderate with debt-to-equity near 0.41, and the company maintains sizable scale - market capitalization in the snapshot is ~$415.5B.

Valuation framing
A few points on valuation: Intel's market cap is now in the mid-hundreds of billions ($415.5B snapshot). That valuation reflects not just current cash flows but expectations of secular AI-driven margin improvement and faster revenue growth. Historically Intel traded as a mature CPU supplier with mid-single-digit growth and mid-teens margins; the new narrative prices in a structural shift toward higher-growth AI infrastructure revenues and improved ASPs on advanced packaging.

That said, trailing EV/EBITDA ~31x and price-to-sales north of 6x imply the market is applying growth multiple assumptions similar to younger, faster-growing peers. The company must deliver revenue execution and margin progression to justify this re-rating. Given the recent earnings surprise and raised guidance, the market is willing to pay up, but the margin for error is smaller now than a year ago.

Trade plan (entry, stop, target, horizon, sizing)

Entry Stop Target Horizon Risk Level
$82.75 $70.00 $120.00 Long term (180 trading days) High

Execution notes: enter immediate long at $82.75. This is a momentum entry that accepts the post-earnings gap; if you prefer a lower-risk entry, leg in on pullbacks toward $75-$78 where buyers may find short-term support. Stop loss at $70.00 sits below the pre-run-up range and provides a clear invalidation level for this thesis: if Intel cannot hold well above prior resistance/support bands after the AI narrative run, the rerating may be premature. Primary target $120.00 assumes continued multiple expansion and execution on data-center penetration and packaging wins; take partial profits along the way at $95 and $105 to de-risk. Time horizon: long term (180 trading days) gives the market time to digest further wins, guide higher, or reveal execution gaps.

Catalysts to push the trade higher

  • Follow-through guidance - incremental raises to revenue and EPS in the next 1-2 quarters that confirm sustained data-center and packaging demand.
  • New customer wins or public design wins for next-gen fabs and packaging (large cloud providers or hyperscalers adopting Intel's process and packaging).
  • Evidence of margin expansion in DCAI or IFS as advanced packaging and node improvements flow through cost structure.
  • Broader semiconductor multiple expansion and continued AI-themed risk-on flows into the sector.

Risks and counterarguments

  • Valuation stretch. At EV/EBITDA ~31x and EV/Sales ~6.96, Intel is priced for strong execution. Any miss on growth or margins will likely result in a sharp multiple contraction.
  • Execution and capital intensity. Free cash flow was negative (-$4.949B) recently; Intel is investing heavily in fabs and packaging. Large capital projects carry timing and cost risk, which can pressure near-term cash flow and margins.
  • Competitive dynamics. GPUs, accelerators, and alternative silicon from competitors can change buyer preferences. If accelerators capture more of the AI workload than expected, CPU pricing and unit demand could soften.
  • Macro and positioning risk. The stock has already rallied hard (up sharply in the last 12 months). Rapid momentum can attract profit-taking, and month-end flows, peg rebalances, or macro shocks (e.g., oil/geopolitical risk) could cause a violent pullback.
  • Sentiment-driven reversion. Technicals are stretched (RSI ~82), and short interest days-to-cover are low (~1.33), so a squeeze could reverse quickly if sentiment shifts.

Counterargument
A reasonable bear case is that the recent beats and guidance are cyclical rather than structural: customer inventories, timing of large cloud purchases, or a handful of near-term design wins could temporarily boost results without guaranteeing sustained secular share gains. If Intel's AI-derived revenue growth decelerates or if gross margins fail to expand as fabs burn cash, the current valuation would not hold. That risk is real and why this trade requires a stop below $70.00 and partial profit-taking at intermediate targets.

What would change my mind
The thesis would materially weaken if: (a) Q2 guidance falls short of raised expectations or management withdraws previously optimistic commentary; (b) free cash flow continues to be strongly negative with no clear inflection in margin trajectory from DCAI/IFS; or (c) large cloud customers publicly shift away from Intel packaging to alternative suppliers en masse. Conversely, sustained guidance raises, improving free cash flow, or high-profile design wins that show Intel as the strategic choice for AI infrastructure would strengthen the bull case and support taking more risk or adding to the position.

Bottom line: Intel's Q1 beat and the re-rating into an AI infrastructure beneficiary are real and actionable, but the market has already rewarded the stock substantially. This trade is a disciplined momentum long: enter at $82.75, stop at $70.00, target $120.00 across a long-term (180 trading days) horizon while taking intermediate profits. Maintain small position size relative to portfolio and use the stop to protect against valuation-driven reversals.

Risks

  • Valuation risk - current multiples imply continued strong growth and margin expansion; misses could trigger sharp multiple contraction.
  • Execution and cash-flow risk - negative free cash flow (-$4.949B) and heavy capex for fabs/packaging could strain finances if timing slips.
  • Competitive risk - accelerators and rival silicon could capture AI workloads, limiting CPU demand and pricing power.
  • Sentiment/technical risk - RSI ~82 indicates overbought conditions; elevated volume and low days-to-cover raise the chance of a quick reversion.

More from Trade Ideas

Quest Diagnostics: Dividend Boost, Buybacks, and Measured Upside — A Tactical Long Apr 24, 2026 RELX: Buy the Repricing — Durable Analytics Growth in a 'SaaSpocalypse' Market Apr 24, 2026 Legend Biotech: Buy the Dip in a CAR-T Growth Story with Real Revenue Traction Apr 24, 2026 First American (FAF) — Buy the Earnings Engine Ahead of a Housing Turnaround Apr 24, 2026 Credo's Optical Bet: Acquisition + Silicon Photonics Could Trigger the Next Leg Up Apr 24, 2026